Immunovant Shares Soared 30% As Investor Trimmed His Stake By $3 Million, But Here’s Why It Still Looks Bullish
On February 17, 2026, Alpine Global Management disclosed a sale of 127,039 shares of immunovant (NASDAQ:IMVT)with an estimated transaction value of $2.83 million based on the quarterly average price. According to a filing with the Securities and Exchange Commission on February 17, 2026, Alpine Global Management reduced its position in Immunovant by 127,039 shares during…